NCT05700448 2026-02-05Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell LymphomaCStone PharmaceuticalsPhase 3 Not yet recruiting150 enrolled
NCT07247227 2025-11-25Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLCPeking Union Medical CollegePhase NA Recruiting150 enrolled